3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
2
Pancreatic Neoplasms
1
Pain, Postoperative
1
Pain, Intractable
1
Neoplasms
1
Neoplasm Metastasis
1
Mucositis
1
Malignant Female Reproductive System Neoplasm
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Duodenal Neoplasms
1
Digestive System Diseases
1
Carcinoma, Hepatocellular
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Agnosia
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Hydromorphone
×
1 year
×
Clear all
No trials found.